Add Yahoo as a preferred source to see more of our stories on Google. AstraZeneca plant in West Chester, Ohio, on Dec. 4, 2021. An experimental drug being developed by AstraZeneca significantly ...
AstraZeneca has secured approval in the US for Calquence (acalabrutinib) plus venetoclax as the first all-oral, fixed-duration regimen to treat adults with chronic lymphocytic leu ...
The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.
AstraZeneca has reported a robust rise in revenue in 2025, driven by strong demand for its cancer medicines, and struck an upbeat note about its prospects for the year ahead.
WASHINGTON – AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump ...
Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...
AstraZeneca showcases three new pioneering drugs at major cancer convention in Berlin. AstraZeneca is enjoying a banner year, averaging a successful phase-three readout every month. The chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results